CAR T-Cell Therapy Market by Product, Target, Indication, Demographic, Region, Competitive Landscape - Global Forecast to 2031

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Key Insights & Market Highlights
2.2 Key Market Participants: Share Insights and Strategic Developments
2.3 Disruptive Trends Shaping Market
2.4 High-Growth Segments & Emerging Frontiers
2.5 Snapshot: Global Market Size, Growth Rate, and Forecast

3.1 Car T-Cell Therapy Market Overview
3.2 North America: Car T-Cell Therapy Market, by Demographic and Country, 2025
3.3 Car T-Cell Therapy Market: Geographic Snapshot

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Technological Advancements in Car T-Cell Therapies
4.2.1.2 Label Expansions and Strong Efficacy Signals in Hematologic Cancers
4.2.1.3 Growing Investment in Car T-Cell Therapy Development
4.2.2 Restraints
4.2.2.1 High Cost and Reimbursement Challenges for Car T-Cell Therapy
4.2.3 Opportunities
4.2.3.1 Expanding Beyond Hematologic Malignancies into Solid Tumors and New Disease Areas
4.2.3.2 Focus Shift on Allogeneic Car-T and Car-Nk
4.2.3.3 Growing Collaborations Among Biopharmaceutical Companies, Academic Institutions, and Research Organizations
4.2.4 Challenges
4.2.4.1 Long-Term Safety Surveillance and Evolving Labeling Requirements
4.3 Unmet Needs & White Spaces
4.4 Interconnected Markets & Cross-Sector Opportunities
4.5 Strategic Moves by Tier-1/2/3 Players
4.6 Pipeline Analysis

5.1 Porter's Five Forces Analysis
5.1.1 Threat of New Entrants
5.1.2 Threat of Substitutes
5.1.3 Bargaining Power of Buyers
5.1.4 Bargaining Power of Suppliers
5.1.5 Intensity of Competitive Rivalry
5.2 Macroeconomic Outlook
5.2.1 Introduction
5.2.2 GDP Trends and Forecasts
5.2.3 Trends in Global Car-T-Cell Therapy Market
5.3 Value Chain Analysis
5.4 Ecosystem Analysis
5.4.1 Role in Ecosystem
5.5 Pricing Analysis
5.5.1 Average Selling Price of Car T-Cell Therapy Products, by Type, 2025
5.5.2 Average Selling Price of Car T-Cell Therapy Products, by Key Player, 2025
5.5.3 Average Selling Price of Car T-Cell Therapy Products, by Region, 2025
5.6 Key Conferences & Events, 2026-2027
5.7 Trends/Disruptions Impacting Customer's Business
5.8 Investment/Funding Scenario
5.9 Impact of 2025 US Tariff on Car T-Cell Therapy Market
5.9.1 Key Tariff Rates
5.9.2 Price Impact Analysis
5.9.3 Impact on Country/Region
5.9.3.1 North America
5.9.3.1.1 US
5.9.3.2 Europe
5.9.3.3 Asia-Pacific
5.9.4 Impact on End-use Industries
5.9.4.1 Hospitals
5.9.4.2 Specialty Oncology Centers
5.9.4.3 Long-Term Care Facilities

6.1 Technology Analysis
6.1.1 Key Technologies
6.1.1.1 Car Design and Optimization
6.1.1.2 Viral Vector Technology
6.1.1.3 Cell Culture and Expansion Techniques
6.1.2 Complementary Technologies
6.1.2.1 Gene Editing Technology (Crispr-Cas9-based Genome Editing)
6.1.3 Adjacent Technologies
6.1.3.1 Monitoring and Imaging Technologies
6.2 Technology/Product Roadmap
6.3 Future Applications
6.4 Impact of AI/Gen AI on Car T-Cell Therapy Market

7.1 Regional Regulations and Compliance
7.1.1 Regulatory Bodies, Government Agencies, and Other Organizations
7.1.2 Regulatory Framework
7.1.3 Industry Standards
7.2 Sustainability Impact and Regulatory Policy Initiatives
7.3 Certifications, Labeling, and Eco-Standards
7.4 Reimbursement Scenario
7.5 Combination Therapies

8.1 Decision-Making Process
8.2 Buyer Stakeholders and Buying Evaluation Criteria
8.2.1 Key Stakeholders in Buying Process
8.2.2 Key Buying Criteria, by End-user
8.3 Adoption Barriers & Internal Challenges
8.4 Unmet Needs from Various End-use Industries
8.5 Market Profitability

9.1 Introduction
9.2 Abecma
9.2.1 Focus on Increased Research Activities for Indication Expansions to Drive Market
9.3 Breyanzi
9.3.1 Need for Treatment of Multiple Indications to Propel Market Growth
9.4 Carvykti
9.4.1 Global Reach and Significant Revenue Growth to Support Market
9.5 Yescarta
9.5.1 Focus on Regulatory Approvals Across Major Regions to Boost Market Growth
9.6 Tecartus
9.6.1 Efforts to Secure Reimbursement and Improve Market Access Facilitate Patient to Aid Market Adoption
9.7 Kymriah
9.7.1 Approval for Pediatric Use to Augment Market Growth
9.8 Other Products

10.1 Introduction
10.2 Cd19
10.2.1 Rising Indication Expansions and New Approvals to Drive Market
10.3 Bcma
10.3.1 Growing Pipeline Products to Propel Market Growth
10.4 Cd19/20
10.4.1 Dual Targeting to Offer Competitive Advantage in Antigen Escape and Tumor Heterogeneity Issues
10.5 Cd7
10.5.1 Allogeneic Cell Source of Cd7 Therapies in Development to Support Growth
10.6 Other Targets

11.1 Introduction
11.2 B-Cell Lymphoma (Bcl)
11.2.1 Rising Prevalence of B-Cell Lymphomas to Propel Market Growth
11.3 Multiple Myeloma
11.3.1 Growing Product Revenue and Rising Global Incidence of Myeloma to Drive Market
11.4 Acute Lymphoblastic Leukemia (All)
11.4.1 Expanding R&D Pipeline to Augment Market Growth
11.5 Other Indications

12.1 Introduction
12.2 Adults
12.2.1 Growing Prevalence of Hematologic Cancers to Drive Market
12.3 Pediatric
12.3.1 High Unmet Needs to Limit Segment Growth

13.1 Introduction
13.2 Hospitals
13.2.1 Growing Need for Standard Oncology Treatment Protocols to Drive Market
13.3 Specialty Centres
13.3.1 Need for Optimal Patient Care and Specialized Treatment Options to Spur Market Growth
13.4 Long-Term Care Facilities
13.4.1 Increasing Incidence of Chronic Disorders Among Geriatric Population to Propel Market Growth

14.1 Introduction
14.2 North America
14.2.1 US
14.2.1.1 US to Dominate Car T-Cell Therapy Market During Study Period
14.2.2 Canada
14.2.2.1 Regulatory Approvals and Government Initiatives for Regenerative Medicine Research to Drive Market
14.3 Europe
14.3.1 Germany
14.3.1.1 Key Product Approvals and Focus on Clinical Research to Aid Market Growth
14.3.2 UK
14.3.2.1 Technological Advancements in Automation and Presence of Robust Research Infrastructure to Spur Market Growth
14.3.3 France
14.3.3.1 Growing Focus on Cell & Gene Therapy Initiatives to Boost Market Growth
14.3.4 Italy
14.3.4.1 Growth in Biotech Sector to Augment Market Growth
14.3.5 Spain
14.3.5.1 Rising Focus on Cell Therapies and Growing Focus on Stringent Regulations to Augment Market Growth
14.3.6 Rest of Europe
14.4 Asia-Pacific
14.4.1 China
14.4.1.1 Rising Number of Car T-Cell Clinical Trials to Fuel Market Growth
14.4.2 Japan
14.4.2.1 Increasing Number of Product Approvals and Rising Geriatric Population to Propel Market Growth
14.4.3 India
14.4.3.1 Growing Focus on Product Commercialization and Rising Cancer Incidence to Boost Market Demand
14.4.4 Australia
14.4.4.1 Robust Infrastructure for Clinical Trials and Well-Developed Healthcare Sector to Aid Market Growth
14.4.5 South Korea
14.4.5.1 Growth in Biopharmaceutical Industry to Facilitate Market Growth
14.4.6 Rest of Asia-Pacific
14.5 Latin America
14.5.1 Brazil
14.5.1.1 Product Approvals and High Healthcare Expenditure to Support Market Growth
14.5.2 Rest of Latin America
14.6 Middle East
14.6.1 GCC Countries
14.6.2 Kingdom of Saudi Arabia
14.6.2.1 Increased Number of Product Approvals and High Healthcare Expenditure to Boost Market Growth
14.6.3 UAE
14.6.3.1 UAE Market Growth to be Driven by Localized Manufacturing, Expanded Clinical Applications, and Strategic Collaborations
14.6.4 Rest of Middle East
14.7 Africa
14.7.1 Significant Burden of Hematologic Malignancies and Infectious Diseases to Propel Market Growth

15.1 Introduction
15.2 Key Player Strategy/Right to Win
15.2.1 Overview of Major Strategies Adopted by Players in Car T-Cell Therapy Market
15.3 Revenue Analysis, 2023-2025
15.4 Market Share Analysis, 2025
15.5 Company Evaluation Matrix: Key Players, 2025
15.5.1 Stars
15.5.2 Emerging Leaders
15.5.3 Pervasive Players
15.5.4 Participants
15.5.5 Company Footprint: Key Players, 2025
15.5.5.1 Company Footprint
15.5.5.2 Region Footprint
15.5.5.3 Product Footprint
15.5.5.4 Target Footprint
15.5.5.5 Indication Footprint
15.6 Company Evaluation Matrix: Startups/SMEs, 2025
15.6.1 Progressive Companies
15.6.2 Responsive Companies
15.6.3 Dynamic Companies
15.6.4 Starting Blocks
15.6.5 Competitive Benchmarking: Startups/SMEs, 2025
15.6.5.1 Detailed List of Key Startups/SMEs
15.6.5.2 Competitive Benchmarking of Startups/SMEs
15.7 Company Valuation & Financial Metrics
15.7.1 Financial Metrics
15.7.2 Company Valuation
15.8 Brand/Product Comparison
15.9 Competitive Scenario
15.9.1 Product Approvals
15.9.2 Deals
15.9.3 Expansions
15.9.4 Other Developments

16.1 Key Players
16.1.1 Johnson & Johnson
16.1.1.1 Business Overview
16.1.1.2 Products Offered
16.1.1.3 Recent Developments
16.1.1.3.1 Product Approvals
16.1.1.3.2 Deals
16.1.1.4 Analyst's View
16.1.1.4.1 Key Strengths
16.1.1.4.2 Strategic Choices
16.1.1.4.3 Weaknesses & Competitive Threats
16.1.2 Gilead Sciences, Inc.
16.1.2.1 Business Overview
16.1.2.2 Products Offered
16.1.2.3 Recent Developments
16.1.2.3.1 Product Approvals
16.1.2.3.2 Deals
16.1.2.3.3 Other Developments
16.1.2.4 Analyst's View
16.1.2.4.1 Key Strengths
16.1.2.4.2 Strategic Choices
16.1.2.4.3 Weaknesses & Competitive Threats
16.1.3 Bristol-Myers Squibb Company
16.1.3.1 Business Overview
16.1.3.2 Products Offered
16.1.3.3 Recent Developments
16.1.3.3.1 Product Approvals
16.1.3.3.2 Deals
16.1.3.4 Analyst's View
16.1.3.4.1 Key Strengths
16.1.3.4.2 Strategic Choices
16.1.3.4.3 Weaknesses & Competitive Threats
16.1.4 Novartis AG
16.1.4.1 Business Overview
16.1.4.2 Products Offered
16.1.4.3 Recent Developments
16.1.4.3.1 Product Approvals
16.1.4.3.2 Other Developments
16.1.4.4 Analyst's View
16.1.4.4.1 Key Strengths
16.1.4.4.2 Strategic Choices
16.1.4.4.3 Weaknesses & Competitive Threats
16.1.5 Autolus Therapeutics
16.1.5.1 Business Overview
16.1.5.2 Products Offered
16.1.5.3 Recent Developments
16.1.5.3.1 Product Approvals
16.1.5.3.2 Deals
16.1.5.4 Analyst's View
16.1.5.4.1 Key Strengths
16.1.5.4.2 Strategic Choices
16.1.5.4.3 Weaknesses & Competitive Threats
16.1.6 Jw (Cayman) Therapeutics Co. Ltd.
16.1.6.1 Business Overview
16.1.6.2 Products Offered
16.1.6.3 Recent Developments
16.1.6.3.1 Product Approvals
16.1.6.3.2 Deals
16.1.7 Immunoadoptive Cell Therapy Private Limited (Immunoact)
16.1.7.1 Business Overview
16.1.7.2 Products Offered
16.1.7.3 Recent Developments
16.1.7.3.1 Deals
16.1.7.3.2 Other Developments
16.1.8 Carsgen Therapeutics Holdings Limited
16.1.8.1 Business Overview
16.1.8.2 Products Offered
16.1.8.3 Recent Developments
16.1.8.3.1 Product Approvals
16.1.8.3.2 Deals
16.1.8.3.3 Expansions
16.1.9 Iaso Biotherapeutics
16.1.9.1 Business Overview
16.1.9.2 Products Offered
16.1.9.3 Recent Developments
16.1.9.3.1 Product Approvals
16.1.9.3.2 Deals
16.1.10 Immuneel Therapeutics
16.1.10.1 Business Overview
16.1.10.2 Products Offered
16.1.10.3 Recent Developments
16.1.10.3.1 Product Launches
16.2 Other Players
16.2.1 Wugen
16.2.2 Cartesian Therapeutics, Inc.
16.2.3 Allogene Therapeutics
16.2.4 Lyell Immunopharma, Inc.
16.2.5 Kyverna Therapeutics, Inc.
16.2.6 Cellictis SA
16.2.7 Brainchild Bio
16.2.8 Atara Biotherapeutics, Inc.
16.2.9 Caribou Biosciences
16.2.10 Arcellx
16.2.11 Crispr Therapeutics
16.2.12 Poseida Therapeutics
16.2.13 Cabaletta Bio

17.1 Research Data
17.1.1 Secondary Data
17.1.1.1 Objectives of Secondary Research
17.1.2 Primary Data
17.1.2.1 Breakdown of Primaries
17.1.2.2 Objectives of Primary Research
17.2 Market Size Estimation
17.2.1 Bottom-Up Approach
17.2.2 Insights from Primary Experts
17.2.3 Segmental Market Size Estimation
17.3 Growth Rate Assumptions
17.3.1 CAGR Projections
17.3.2 Impact of Supply- and Demand-Side Factors
17.4 Data Triangulation
17.5 Research Limitations
17.6 Study Assumptions
17.7 Risk Analysis

18.1 Discussion Guide
18.2 Knowledgestore: The Subscription Portal
18.3 Customization Options

Table 1 Car T-Cell Therapy Market: Inclusions & Exclusions
Table 2 Key Pipeline Products in Phase-2 and Phase-3 Car T-Cell Therapy Market (As of 2025)
Table 3 Impact of Porter's Five Forces on Car T-Cell Therapy Market
Table 4 Role of Major Companies in Car T-Cell Therapy Market Ecosystem (Supply and Demand Sides)
Table 5 Average Selling Price of Car T-Cell Therapy Products, by Type, 2025 (USD)
Table 6 Average Selling Price of Car T-Cell Therapy Products, by Region, 2025
Table 7 Key Conferences & Events in Car T-Cell Therapy Market, January 2026-December 2027
Table 8 US-Adjusted Reciprocal Tariff Rates
Table 9 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Country-Wise Regulatory Scenario for Car T-Cell Therapy Product Manufacturers
Table 14 Car T-Cell Therapy Market: Reimbursement Status and Funding Channel, by Country/Region (As of 2026)
Table 15 Car T-Cell Therapy Market: Hcpcs Codes of Commercialized Therapies
Table 16 Combination Therapy Trials in Car T-Cell Therapy Market
Table 17 Influence of Key Stakeholders on Buying Process, by End-user (%)
Table 18 Key Buying Criteria, by End-user
Table 19 Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 20 Car T-Cell Therapy Market, by Region, 2024-2031 (Number of Therapies)
Table 21 Car T-Cell Therapy Market for Abecma, by Region, 2024-2031 (USD Million)
Table 22 North America: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 23 Europe: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 24 Asia-Pacific: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 25 Latin America: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 26 Middle East: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 27 GCC Countries: Car T-Cell Therapy Market for Abecma, by Country, 2024-2031 (USD Million)
Table 28 Car T-Cell Therapy Market for Breyanzi, by Region, 2024-2031 (USD Million)
Table 29 North America: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 30 Europe: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 31 Asia-Pacific: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 32 Latin America: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 33 Middle East: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 34 GCC Countries: Car T-Cell Therapy Market for Breyanzi, by Country, 2024-2031 (USD Million)
Table 35 Car T-Cell Therapy Market for Carvykti, by Region, 2024-2031 (USD Million)
Table 36 North America: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 37 Europe: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 38 Asia-Pacific: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 39 Latin America: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 40 Middle East: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 41 GCC Countries: Car T-Cell Therapy Market for Carvykti, by Country, 2024-2031 (USD Million)
Table 42 Car T-Cell Therapy Market for Yescarta, by Region, 2024-2031 (USD Million)
Table 43 North America: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 44 Europe: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 45 Asia-Pacific: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 46 Latin America: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 47 Middle East: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 48 GCC Countries: Car T-Cell Therapy Market for Yescarta, by Country, 2024-2031 (USD Million)
Table 49 Car T-Cell Therapy Market for Tecartus, by Region, 2024-2031 (USD Million)
Table 50 North America: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 51 Europe: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 52 Asia-Pacific: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 53 Latin America: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 54 Middle East: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 55 GCC Countries: Car T-Cell Therapy Market for Tecartus, by Country, 2024-2031 (USD Million)
Table 56 Car T-Cell Therapy Market for Kymriah, by Region, 2024-2031 (USD Million)
Table 57 North America: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 58 Europe: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 59 Asia-Pacific: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 60 Latin America: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 61 Middle East: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 62 GCC Countries: Car T-Cell Therapy Market for Kymriah, by Country, 2024-2031 (USD Million)
Table 63 Car T-Cell Therapy Market for Other Products, by Region, 2024-2031 (USD Million)
Table 64 North America: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 65 Europe: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 66 Asia-Pacific: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 67 Latin America: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 68 Middle East: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 69 GCC Countries: Car T-Cell Therapy Market for Other Products, by Country, 2024-2031 (USD Million)
Table 70 Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 71 Commercially Available Cd19 Antigen Targeting Car T-Cell Therapies
Table 72 Cd19-Targeting Car T-Cell Therapy Market, by Region, 2024-2031 (USD Million)
Table 73 North America: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 74 Europe: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 75 Asia-Pacific: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 76 Latin America: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 77 Middle East: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 78 GCC Countries: Cd19-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 79 Commercially Available Bcma Antigen Targeting Car T-Cell Therapies
Table 80 Bcma-Targeting Car T-Cell Therapy Market, by Region, 2024-2031 (USD Million)
Table 81 North America: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 82 Europe: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 83 Asia-Pacific: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 84 Latin America: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 85 Middle East: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 86 GCC Countries: Bcma-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 87 Cd19/20-Targeting Car T-Cell Therapy Market, by Region, 2024-2031 (USD Million)
Table 88 North America: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 89 Europe: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 90 Asia-Pacific: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 91 Latin America: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 92 Middle East: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 93 GCC Countries: Cd19/20-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 94 Cd7-Targeting Car T-Cell Therapy Market, by Region, 2024-2031 (USD Million)
Table 95 North America: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 96 Europe: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 97 Asia-Pacific: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 98 Latin America: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 99 Middle East: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 100 GCC Countries: Cd7-Targeting Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 101 Other Car T-Cell Therapy Targets Market, by Region, 2024-2031 (USD Million)
Table 102 North America: Other Car T-Cell Therapy Targets Market, by Country, 2024-2031 (USD Million)
Table 103 Europe: Other Car T-Cell Therapy Targets Market, by Country, 2024-2031 (USD Million)
Table 104 Asia-Pacific: Other Car T-Cell Therapy Targets Market, by Country, 2024-2031 (USD Million)
Table 105 Latin America: Other Car T-Cell Therapy Targets Market, by Country, 2024-2031 (USD Million)
Table 106 Middle East: Other Car T-Cell Therapy Targets Market, by Country, 2024-2031 (USD Million)
Table 107 GCC Countries: Other Car T-Cell Therapy Targets Marketa, by Country, 2024-2031 (USD Million)
Table 108 Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 109 Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Region, 2024-2031 (USD Million)
Table 110 North America: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 111 Europe: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 112 Asia-Pacific: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 113 Latin America: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 114 Middle East: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 115 GCC Countries: Car T-Cell Therapy Market for B-Cell Lymphoma (Bcl), by Country, 2024-2031 (USD Million)
Table 116 Car T-Cell Therapy Market for Multiple Myeloma, by Region, 2024-2031(USD Million)
Table 117 North America: Car T-Cell Therapy Market for Multiple Myeloma, by Country, 2024-2031(USD Million)
Table 118 Europe: Car T-Cell Therapy Market for Multiple Myeloma, by Country, 2024-2031(USD Million)
Table 119 Asia-Pacific: Car T-Cell Therapy Market for Multiple Myeloma, by Country, 2024-2031(USD Million)
Table 120 Latin America: Car T-Cell Therapy Market for Multiple Myeloma, by Country, 2024-2031 (USD Million)
Table 121 Middle East: Car T-Cell Therapy Market for Multiple Myeloma, by Country, 2024-2031 (USD Million)
Table 122 GCC Countries: Car T-Cell Therapy Market for Multiple Myelloma, by Country, 2024-2031 (USD Million)
Table 123 Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Region, 2024-2031(USD Million)
Table 124 North America: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031(USD Million)
Table 125 Europe: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031(USD Million)
Table 126 Asia-Pacific: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031(USD Million)
Table 127 Latin America: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031 (USD Million)
Table 128 Middle East: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031 (USD Million)
Table 129 GCC Countries: Car T-Cell Therapy Market for Acute Lymphoblastic Leukemia (All), by Country, 2024-2031 (USD Million)
Table 130 Car T-Cell Therapy Market for Other Indications, by Region, 2024-2031 (USD Million)
Table 131 North America: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 132 Europe: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 133 Asia-Pacific: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 134 Latin America: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 135 Middle East: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 136 GCC Countries: Car T-Cell Therapy Market for Other Indications, by Country, 2024-2031 (USD Million)
Table 137 Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 138 Car T-Cell Therapy Market for Adults, by Region, 2024-2031 (USD Million)
Table 139 North America: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 140 Europe: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 141 Asia-Pacific: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 142 Latin America: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 143 Middle East: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 144 GCC Countries: Car T-Cell Therapy Market for Adults, by Country, 2024-2031 (USD Million)
Table 145 Car T-Cell Therapy Market for Pediatric, by Region, 2024-2031 (USD Million)
Table 146 North America: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031 (USD Million)
Table 147 Europe: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031 (USD Million)
Table 148 Asia-Pacific: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031 (USD Million)
Table 149 Latin America: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031 (USD Million)
Table 150 Middle East: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031(USD Million)
Table 151 GCC Countries: Car T-Cell Therapy Market for Pediatric, by Country, 2024-2031(USD Million)
Table 152 Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 153 Car T-Cell Therapy Market for Hospitals, by Region, 2024-2031 (USD Million)
Table 154 North America: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031 (USD Million)
Table 155 Europe: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031 (USD Million)
Table 156 Asia-Pacific: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031(USD Million)
Table 157 Latin America: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031 (USD Million)
Table 158 Middle East: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031 (USD Million)
Table 159 GCC Countries: Car T-Cell Therapy Market for Hospitals, by Country, 2024-2031(USD Million)
Table 160 Car T-Cell Therapy Market for Specialty Centres, by Region, 2024-2031 (USD Million)
Table 161 North America: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031 (USD Million)
Table 162 Europe: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031 (USD Million)
Table 163 Asia-Pacific: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031 (USD Million)
Table 164 Latin America: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031 (USD Million)
Table 165 Middle East: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031(USD Million)
Table 166 GCC Countries: Car T-Cell Therapy Market for Specialty Centres, by Country, 2024-2031(USD Million)
Table 167 Car T-Cell Therapy Market for Long-Term Care Facilities, by Region, 2024-2031(USD Million)
Table 168 North America: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 169 Europe: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 170 Asia-Pacific: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 171 Latin America: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 172 Middle East: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 173 GCC Countries: Car T-Cell Therapy Market for Long-Term Care Facilities, by Country, 2024-2031(USD Million)
Table 174 Car T-Cell Therapy Market, by Region, 2024-2031 (USD Million)
Table 175 North America: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 176 North America: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 177 North America: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 178 North America: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 179 North America: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 180 North America: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 181 US: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 182 US: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 183 US: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 184 US: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 185 US: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 186 Canada: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 187 Canada: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 188 Canada: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 189 Canada: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 190 Canada: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 191 Europe: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 192 Europe: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 193 Europe: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 194 Europe: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 195 Europe: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 196 Europe: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 197 Germany: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 198 Germany: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 199 Germany: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 200 Germany: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 201 Germany: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 202 UK: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 203 UK: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 204 UK: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 205 UK: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 206 UK: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 207 France: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 208 France: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 209 France: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 210 France: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 211 France: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 212 Italy: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 213 Italy: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 214 Italy: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 215 Italy: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 216 Italy: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 217 Spain: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 218 Spain: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 219 Spain: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 220 Spain: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 221 Spain: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 222 Rest of Europe: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 223 Rest of Europe: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 224 Rest of Europe: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 225 Rest of Europe: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 226 Rest of Europe: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 227 Asia-Pacific: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 228 Asia-Pacific: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 229 Asia-Pacific: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 230 Asia-Pacific: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 231 Asia-Pacific: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 232 Asia-Pacific: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 233 China: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 234 China: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 235 China: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 236 China: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 237 China: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 238 Japan: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 239 Japan: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 240 Japan: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 241 Japan: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 242 Japan: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 243 India: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 244 India: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 245 India: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 246 India: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 247 India: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 248 Australia: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 249 Australia: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 250 Australia: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 251 Australia: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 252 Australia: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 253 South Korea: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 254 South Korea: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 255 South Korea: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 256 South Korea: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 257 South Korea: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 258 Rest of Asia Pacifc: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 259 Rest of Asia-Pacific: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 260 Rest of Asia-Pacific: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 261 Rest of Asia-Pacific: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 262 Rest of Asia-Pacific: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 263 Latin America: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 264 Latin America: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 265 Latin America: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 266 Latin America: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 267 Latin America: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 268 Latin America: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 269 Brazil: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 270 Brazil: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 271 Brazil: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 272 Brazil: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 273 Brazil: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 274 Rest of Latin America: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 275 Rest of Latin America: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 276 Rest of Latin America: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 277 Rest of Latin America: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 278 Rest of Latin America: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 279 Middle East: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 280 Middle East: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 281 Middle East: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 282 Middle East: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 283 Middle East: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 284 Middle East: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 285 GCC Countries: Car T-Cell Therapy Market, by Country, 2024-2031 (USD Million)
Table 286 GCC Countries: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 287 GCC Countries: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 288 GCC Countries: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 289 GCC Countries: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 290 GCC Countries: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 291 Kingdom of Saudi Arabia: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 292 Kingdom of Saudi Arabia: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 293 Kingdom of Saudi Arabia: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 294 Kingdom of Saudi Arabia: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 295 Kingdom of Saudi Arabia: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 296 UAE: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 297 UAE: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 298 UAE: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 299 UAE: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 300 UAE: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 301 Rest of Middle East: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 302 Rest of Middle East: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 303 Rest of Middle East: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 304 Rest of Middle East: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 305 Rest of Middle East: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 306 Africa: Car T-Cell Therapy Market, by Product, 2024-2031 (USD Million)
Table 307 Africa: Car T-Cell Therapy Market, by Target, 2024-2031 (USD Million)
Table 308 Africa: Car T-Cell Therapy Market, by Indication, 2024-2031 (USD Million)
Table 309 Africa: Car T-Cell Therapy Market, by Demographic, 2024-2031 (USD Million)
Table 310 Africa: Car T-Cell Therapy Market, by End-user, 2024-2031 (USD Million)
Table 311 Overview of Major Strategies Adopted by Key Players in Car T-Cell Therapy Market
Table 312 Car T-Cell Therapy Market: Degree of Competition
Table 313 Car T-Cell Therapy Market: Region Footprint
Table 314 Car T-Cell Therapy Market: Product Footprint
Table 315 Car T-Cell Therapy Market: Target Footprint
Table 316 Car T-Cell Therapy Market: Indication Footprint
Table 317 Car T-Cell Therapy Market: Detailed List of Key Startups/SME Players
Table 318 Car T-Cell Therapy Market: Competitive Benchmarking of Startups/SME Players, by Demography and Region, 2025
Table 319 Car T-Cell Therapy Market: Product Approvals, January 2022-January 2026
Table 320 Car T-Cell Therapy Market: Deals, January 2022-January 2026
Table 321 Car T-Cell Therapy Market: Expansions, January 2022-January 2026
Table 322 Car T-Cell Therapy Market: Other Developments, January 2022-January 2026
Table 323 Johnson & Johnson: Company Overview
Table 324 Johnson & Johnson: Products Offered
Table 325 Johnson & Johnson: Product Approvals, January 2022-January 2026
Table 326 Johnson & Johnson: Deals, January 2022-January 2026
Table 327 Gilead Sciences, Inc.: Company Overview
Table 328 Gilead Sciences, Inc.: Products Offered
Table 329 Gilead Sciences, Inc.: Product Approvals, January 2022-January 2026
Table 330 Gilead Sciences, Inc.: Deals, January 2022-January 2026
Table 331 Gilead Sciences, Inc.: Other Developments, January 2022-January 2026
Table 332 Bristol-Myers Squibb Company: Company Overview
Table 333 Bristol-Myers Squibb Company: Products Offered
Table 334 Bristol-Myers Squibb Company: Product Approvals, January 2022-January 2026
Table 335 Bristol-Myers Squibb Company: Deals, January 2022-January 2026
Table 336 Novartis AG: Company Overview
Table 337 Novartis AG: Products Offered
Table 338 Novartis AG: Product Approvals, January 2022-January 2026
Table 339 Novartis AG: Other Developments, January 2022-January 2026
Table 340 Autolus Therapeutics: Company Overview
Table 341 Autolus Therapeutics: Products Offered
Table 342 Autolus Therapeutics: Product Approvals, January 2022-January 2026
Table 343 Autolus Therapeutics: Deals, January 2022-January 2026
Table 344 Jw (Cayman) Therapeutics Co. Ltd.: Company Overview
Table 345 Jw (Cayman) Therapeutics Co. Ltd.: Products Offered
Table 346 Jw (Cayman) Therapeutics Co. Ltd.: Product Approvals, January 2022-January 2026
Table 347 Jw (Cayman) Therapeutics Co. Ltd.: Deals, January 2022-January 2026
Table 348 Immunoadoptive Cell Therapy Private Limited (Immunoact): Company Overview
Table 349 Immunoadoptive Cell Therapy Private Limited (Immunoact): Products Offered
Table 350 Immunoadoptive Cell Therapy Private Limited (Immunoact): Deals, January 2022-January 2026
Table 351 Immunoadoptive Cell Therapy Private Limited (Immunoact): Other Developments, January 2022-January 2026
Table 352 Carsgen Therapeutics Holdings Limited: Company Overview
Table 353 Carsgen Therapeutics Holdings Limited: Products Offered
Table 354 Carsgen Therapeutics Holdings Limited: Product Approvals, January 2022-January 2026
Table 355 Carsgen Therapeutics Holdings Limited: Deals, January 2022-January 2026
Table 356 Carsgen Therapeutics Holdings Limited: Expansions, January 2022-January 2026
Table 357 Iaso Biotherapeutics: Company Overview
Table 358 Iaso Biotherapeutics: Products Offered
Table 359 Iaso Biotherapeutics: Product Approvals, January 2022-January 2026
Table 360 Iaso Biotherapeutics: Deals, January 2022-January 2026
Table 361 Immuneel Therapeutics: Company Overview
Table 362 Immuneel Therapeutics: Products Offered
Table 363 Immuneel Therapeutics: Product Launches, January 2022-January 2026
Table 364 Wugen: Company Overview
Table 365 Cartesian Therapeutics, Inc.: Company Overview
Table 366 Allogene Therapeutics: Company Overview
Table 367 Lyell Immunopharma, Inc.: Company Overview
Table 368 Kyverna Therapeutics, Inc.: Company Overview
Table 369 Cellictis SA: Company Overview
Table 370 Brainchild Bio: Company Overview
Table 371 Atara Biotherapeutics, Inc.: Company Overview
Table 372 Caribou Biosciences: Company Overview
Table 373 Arcellx: Company Overview
Table 374 Crispr Therapeutics: Company Overview
Table 375 Poseida Therapeutics: Company Overview
Table 376 Cabaletta Bio: Company Overview
Table 377 Impact Analysis of Supply- and Demand-Side Factors on Car T-Cell Therapy Market
Table 378 Car T-Cell Therapy Market: Risk Analysis

Figure 1 Car T-Cell Therapy Market Segmentation & Regional Scope
Figure 2 Car T-Cell Therapy Market: Years Considered
Figure 3 Car T-Cell Therapy Market Scenario
Figure 4 Global Car T-Cell Therapy Market Size, 2024-2031 (USD Million)
Figure 5 Major Strategies Adopted by Key Players in Car T-Cell Therapy Market, 2023-2025
Figure 6 Disruptions Influencing Growth of Car T-Cell Therapy Market
Figure 7 High-Growth Segments in Car T-Cell Therapy Market, by Product, Target, End-user, and Region, 2026-2031
Figure 8 Asia-Pacific to Register Highest CAGR in Car T-Cell Therapy Market, in Terms of Value, During Forecast Period
Figure 9 Technological Advancements in Car T-Cell Therapies to Drive Growth
Figure 10 US and Adults Dominated North American Car T-Cell Therapy Market in 2025
Figure 11 India to Register Fastest Growth Rate During Forecast Period
Figure 12 Car T-Cell Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 13 Global Car T-Cell Therapy Trials Distribution, by Target (Across All Phases of Development), 2025
Figure 14 Global Car T-Cell Therapy Trials Distribution of Target by Development Phase, 2025
Figure 15 Car T-Cell Therapy Market: Porter's Five Forces Analysis
Figure 16 Car T-Cell Therapy Market: Value Chain Analysis
Figure 17 Car T-Cell Therapy Market: Ecosystem Analysis
Figure 18 Average Selling Price of Car T-Cell Therapy Products, by Key Player, 2025 (USD)
Figure 19 Trends/Disruptions Impacting Customer's Business in Car T-Cell Therapy Market
Figure 20 Funding and Number of Deals in Car T-Cell Therapy Market (USD Million)
Figure 21 Impact of AI/Gen AI on Car T-Cell Therapy Market
Figure 22 Influence of Key Stakeholders on Buying Process, by End-user
Figure 23 Key Buying Criteria for Major End-users
Figure 24 North America: Car T-Cell Therapy Market Snapshot
Figure 25 Asia-Pacific: Car T-Cell Therapy Market Snapshot
Figure 26 Revenue Analysis of Key Players in Car T-Cell Therapy Market, 2023-2025 (USD Million)
Figure 27 Market Share Analysis of Key Players in Car T-Cell Therapy Market (2025)
Figure 28 Car T-Cell Therapy Market: Company Evaluation Matrix (Key Players), 2025
Figure 29 Car T-Cell Market: Company Footprint
Figure 30 Car T-Cell Therapy Market: Company Evaluation Matrix (Startups/SMEs), 2025
Figure 31 EV/EBITDA of Key Vendors
Figure 32 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 33 Car T-Cell Therapy Market: Brand/Product Comparative Analysis
Figure 34 Johnson & Johnson: Company Snapshot
Figure 35 Gilead Sciences, Inc.: Company Snapshot
Figure 36 Bristol-Myers Squibb Company: Company Snapshot
Figure 37 Novartis AG: Company Snapshot
Figure 38 Jw (Cayman) Therapeutics Co. Ltd.: Company Snapshot
Figure 39 Carsgen Therapeutics Holdings Limited: Company Snapshot
Figure 40 Car T-Cell Therapy Market: Research Design
Figure 41 Car T-Cell Therapy Market: Breakdown of Demand- and Supply-Side Primaries
Figure 42 Car T-Cell Therapy Market Size Estimation (Supply-Side Analysis), 2025
Figure 43 Car T-Cell Therapy Market Size Estimation: Company Revenue Analysis-based Estimation (Products), 2025
Figure 44 Illustrative Example of Gilead Sciences, Inc.: Revenue Share Analysis (2025)
Figure 45 Car T-Cell Therapy Market Validation from Primary Sources
Figure 46 Car T-Cell Therapy Market Size Estimation Methodology: Top-Down Approach
Figure 47 Car T-Cell Therapy Market: CAGR Projections, 2026-2031
Figure 48 Car T-Cell Therapy Market: Data Triangulation Methodology